We are CASI
We are CASI

An innovative biopharmaceutical company
focused on hematology oncology therapeutics
and therapeutics for organ transplant rejection
and autoimmune disease

Learn More
We are CASI
We are CASI

We explore innovative therapies to
save patients' lives

Learn More
About Us
CASI is a NASDAQ-listed biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.
The Company is focused on acquiring, developing, and commercializing products that augment its focus on hematology oncology therapeutics and therapeutics for organ transplant rejection and autoimmune disease, as well as other areas of unmet medical need.
Learn More
An innovative biopharmaceutical company focused on unmet medical needs
What We Do
Portfolio

Dedicate to hematologic malignancies & oncology

News

Latest press releases, media assets and global media contacts

Learn More
lnvestors

Continues to create value for shareholders and the society

Financial Reports
Careers
Bring together outstanding people
Learn More